briefings and notes

This report examines the impact of the COVID-19 pandemic on the illicit drug market. It was prepared by the UNODC Global Research Network and is based on the most recent data from...

This document provides an update on harm reduction activities during the pandemic in the Nethderlands.

On this info page Drugreporter updates you about how European harm reduction service providers mitigate the risks of COVID-19 infections and protect their clients, who are among the most at risk groups...

This paper, prepared at the request of the HDG of the Council of the EU, is intended to provide a short overview of issues pertinent to European participation in the planned CND...

This is the revised EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe presented during the Horizontal Working Party on Drugs meeting held on 6 February 2013.

This short report, Prepared by the EMCDDA at the request of the Pompidou Group Secretariat, undertakes a comparison between the national interventions in the area of substitution treatment with classified substances, and...

One of the targets of the EU action plan is ‘to reduce significantly over five years the prevalence of drug use, as well as new recruitment to it, particularly among young people...

Written to contribute to the European Commission's Communication on evaluation of the EU Action Plan, this paper highlights evidence of legislative activity related to new synthetic drugs as an indicator of Member...

Drug use is directly or indirectly prohibited in all EU countries – except for in medical or scientific circumstances – and punishment for offences varies from administrative to penal, depending on the...

This thematic paper, contributing to the European Commission's evaluation of the EU Action Plan 2000-2004, looks at the extent to which legislative attention was paid in the period to actions considered by...